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Introduction {#sec1}
============

Diet-induced obesity is often associated with increased free fatty acid (FFA) levels in circulating blood; these are considered to be a major risk factor for the development of type 2 diabetes and cardiovascular disease ([@bib3], [@bib12]). On a cellular level, an excess of unsaturated FFAs increases the triacylglycerol (TAG) pool in lipid droplets ([@bib30]). Excess saturated FFAs increase the diacylglycerol (DAG) pool in the endoplasmic reticulum (ER) ([@bib2], [@bib27]), and the accumulation of ceramide (Cer) ([@bib6]). The accumulation of intracellular Cer and DAG is thought to modulate intracellular signaling cascades, leading to impaired insulin signaling *in vitro* and *in vivo* ([@bib7], [@bib9]).

Several lines of evidence link sphingolipid metabolism, in particular Cer processing, to the development of diabetes, liver steatosis, and cardiovascular diseases ([@bib7], [@bib15]). The first step in sphingolipid biosynthesis toward the sphingoid base is catalyzed by serine-palmitoyl CoA transferase (SPT), facilitating the condensation of L-serine and palmitoyl CoA. Pharmacological inhibition of SPT activity led to the retention of insulin sensitivity in muscle cells with saturated FFA-induced stress ([@bib41]). Similarly, *SPT2* heterozygous deficiency protected mice from diet-induced insulin resistance ([@bib24]). Condensation of sphingoid base with acyl-CoA is facilitated by a family of six ceramide synthases (CerSs). Each CerS exhibited a distinct tissue distribution and preferred acyl chain length ([@bib28]). Human *CerS6* mRNA expression in adipose tissues is positively correlated with body mass index ([@bib37]), and ablation of *CerS5* or *CerS6* genes in mice prevents high-fat-diet-induced obesity and insulin resistance ([@bib11], [@bib37]). By contrast, *CerS2* haploinsufficiency led to a compensatory increase in C16-Cer and raised the susceptibility to diet-induced hepatosteatosis and insulin resistance ([@bib29]).

Cer is a key intermediate of the sphingolipid metabolism and the last common precursor of sphingomyelin (SM) and glucosylceramide biosyntheses. SM biosynthesis is catalyzed by two key enzymes, sphingomyelin synthase 1 (SMS1) and SMS2. Both enzymes act as phosphatidylcholine:ceramide phosphocholine transferase, by facilitating transfer of the phosphorylcholine head group from the phosphatidylcholine (PC) to Cer, generating SM and DAG ([@bib25]). SMS1 resides in the Golgi apparatus, and its deficiency leads to mitochondrial dysfunction and a defect in insulin secretion ([@bib43], [@bib44]). SMS2 is localized in both the Golgi apparatus and the plasma membrane (PM), in particular in lipid rafts. Its deficiency ameliorates diet-induced obesity and insulin resistance ([@bib24], [@bib26], [@bib32]). Although *SMS1* and *SMS2* deficiencies produce only a marginal effect for Cer, DAG, and SM content in tissues or cells, the molecular mechanism underlying the related phenotypes in knockout mice remains elusive.

We previously reported that *GPRC5B* deficiency in mice protects from diet-induced obesity and insulin resistance. GPRC5B recruitment of Src-family kinase (SFK) Fyn was critical for chronic inflammation and insulin resistance in adipose tissues ([@bib21]). This suggests that GPRC5B plays a significant role in the metabolic regulation of insulin-sensitive organs, including the CNS, muscles, and adipose tissues. Interestingly, under nutrient excess condition, *GPRC5B* as well as *SMS2* knockout mice produced highly similar metabolic phenotypes, especially in regard to insulin resistance, raising the possibility of affecting a similar influence on lipid metabolism. Furthermore, both proteins are similarly distributed in the PM and Golgi apparatus, and they co-fractionate into detergent-resistant membranes. Thus, we hypothesized that GPRC5B and SMS2 might share a functional connection to mediate lipid metabolism under metabolic stress conditions. In this study, we determined whether there is a functional connection between GPRC5B and SMS2 concerning the regulation of sphingolipid metabolism and insulin signaling under FFA-induced metabolic stress conditions.

Results {#sec2}
=======

Metabolic Stress Facilitates the Interaction of GPRC5B and SMS2, and SMS2 Phosphorylation {#sec2.1}
-----------------------------------------------------------------------------------------

Our initial study focused on identifying potential GPRC5B-interacting partners and the consequences of the resulting GPRC5B-mediated phosphorylation. Because SMS2 is considered to be a candidate interacting partner of GPRC5B, we tested whether their association occurs in cells. We co-transfected cells with expression plasmids encoding SMS2 and either wild-type (5b-WT) or mutant (5b-YF) GPRC5B. This mutant has a defect in Fyn-recruiting activity ([@bib21]). SMS2 specifically interacted with both wild-type (WT) and mutant GPRC5B ([Figure 1](#fig1){ref-type="fig"}A). There were no obvious changes in this interaction, suggesting that Fyn-recruiting activity does not influence the association of GPRC5B and SMS2.Figure 1Metabolic Stress Facilitates the Interaction of GPRC5B and SMS2 and SMS2 Phosphorylation(A) Interaction between GPRC5B and SMS2 was measured using co-immunoprecipitation (IP). COS7 cells were transfected with expression plasmids for SMS2-Flag and either 5b-WT or mutant 5b-YF. Empty vector (EV) was used as a negative control. SMS2-Flag was immunoprecipitated using Flag beads. GPRC5B in the immunoprecipitates was detected using SDS-PAGE and western blotting.(B and C) Palmitate exposure enhances GPRC5B-SMS2 interaction. (B) COS7 cells were transfected with the indicated expression plasmids. After 24 hr of transfection, culture medium was replaced with serum-free medium containing palmitate-BSA complex for the indicated times. GPRC5B-Flag was immunoprecipitated using Flag beads. Immunoprecipitates were digested with PNGase F to remove N-linked glycans from GPRC5B and then subjected to SDS-PAGE. Data are means ± SEM (n = 3; ANOVA, \*\*p \< 0.01). (C) COS7 cells were co-transfected with expression plasmids for SMS2-AcGFP and GPRC5B-Flag. After 8 hr of palmitate treatment, cells were fixed and labeled with anti-Flag antibody. Alexa 546-labeled secondary antibody was used to visualize GPRC5B. Fluorescence images were obtained with an FV1000 confocal microscope (Olympus). Sensitized emission fluorescence resonance energy transfer (FRET) was measured. FRET values for individual cells are plotted, and means ± SEM superimposed (n = 52; Student\'s t test). Palm, palmitate; BSA, vehicle control. Scale bar, 10 μm.(D) SFK inhibitor, Su6656 blocked palmitate-induced SMS2 phosphorylation. Transfected COS7 cells with the indicated expression plasmids were pretreated with 10 μM of Su6656 and then stimulated with 0.5 mM palmitate for 8 hr. After stimulation, SMS2-Flag was immunoprecipitated, and then tyrosine phosphorylation was detected using anti-phosphotyrosine antibody. Data are means ± SEM (n = 3; ANOVA, \*\*\*p \< 0.001).(E) GPRC5B-SMS2 interaction enhances SMS2 tyrosine phosphorylation by recruiting SFK under metabolic stress. After 8 hr of palmitate treatment, SMS was immunoprecipitated.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Metabolic stress can result from chronic nutritional changes, such as that caused by starvation or by induced cellular stress related to nutrient excess ([@bib42]). Cell culture in the medium supplemented with palmitate is a representative model system for lipid-induced insulin resistance. We next examined whether this interaction is affected by palmitate-induced metabolic stress. The association of GPRC5B and SMS2 significantly increased by palmitate exposure ([Figure 1](#fig1){ref-type="fig"}B). By contrast, GPRC5B\'s association with SMS1 did not increase. The enhanced interaction between GPRC5B and SMS2 was also demonstrated using fluorescence resonance energy transfer microscopy, showing that metabolic stress facilitates the association of these two proteins ([Figure 1](#fig1){ref-type="fig"}C).

Phorbol 12-myristate 13-acetate (PMA) is a potent activator for protein kinase C (PKC), and generates reactive oxygen species. This triggers subsequent signaling cascades leading to activate SFK. PMA treatment also enhanced the interaction between GPRC5B and SMS2 ([Figure S1](#mmc1){ref-type="supplementary-material"}). Interestingly, SMS2-associated GPRC5B showed altered glycosylation patterns ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). We confirmed N-linked glycosylation of GPRC5B by PNGase F digestion ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Differential glycosylation of GPRC5B-SMS2 complex suggests that their interaction occurs in the ER and Golgi apparatus to influence the glycosylation process.

Next, we determined whether SMS2 phosphorylation depends on the SFK-recruiting activity of GPRC5B. Pretreatment with Su6656, an SFK inhibitor, completely blocked palmitate-induced SMS2 phosphorylation ([Figure 1](#fig1){ref-type="fig"}D), indicating that SFK is involved in this process. In addition, palmitate-induced tyrosine phosphorylation of SMS2 was apparently increased in cells co-transfected with WT GPRC5B but not with mutant GPRC5B (GPRC5B-YF) ([Figure 1](#fig1){ref-type="fig"}E), suggesting that the SFK-recruiting activity of GPRC5B is critical for SMS2 phosphorylation under metabolic stress. Palmitate exposure did not affect SMS1 phosphorylation ([Figure 1](#fig1){ref-type="fig"}E). The SFK-recruiting activity of GPRC5B also enhances tyrosine phosphorylation of SMS2 after PMA treatment ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Pretreatment with Su6656 also reduced SMS2 phosphorylation by PMA exposure ([Figure S1](#mmc1){ref-type="supplementary-material"}D).

Phosphorylation of Cytoplasmic Tyrosine Residues Increases SMS2 Protein Abundance {#sec2.2}
---------------------------------------------------------------------------------

PMA treatment gradually elevated SMS2 abundance ([Figure S1](#mmc1){ref-type="supplementary-material"}A), and SMS2 level was positively correlated with its tyrosine phosphorylation ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). To examine how phosphorylation of SMS2 regulates its protein abundance, we assessed Fyn-mediated phosphorylation of SMS2. We observed significant elevation of SMS2 protein level accompanied by robust tyrosine phosphorylation in cells co-transfected with constitutively active Fyn (Fyn-CA) ([Figure 2](#fig2){ref-type="fig"}A). Although WT Fyn (Fyn-WT) increases SMS2 phosphorylation, SMS2 protein level does not change ([Figure 2](#fig2){ref-type="fig"}A). This suggests that persistent phosphorylation is required to increase SMS2 protein level. We also compared Fyn-mediated phosphorylation of SMS1 with that of SMS2 and observed that Fyn phosphorylated SMS1 to a lesser extent than it did SMS2 ([Figure S2](#mmc1){ref-type="supplementary-material"}A).Figure 2Tyrosine Phosphorylation of SMS2 Increases its Protein Abundance(A) Tyrosine phosphorylation increases the expression level of SMS2. Co-transfection with constitutively active Fyn (Fyn-CA, Y528F) and SMS2 in COS7 cells increased the expression of SMS2. Kinase-dead mutant Fyn (Fyn-KD, K299M) did not affect SMS2 phosphorylation. To quantify tyrosine phosphorylation level precisely, we adjusted cell lysates to have similar amounts of SMS2 in the immunoprecipitate (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}). An EGFP expression plasmid was used as an internal standard to control transfection efficiency.(B) Tyrosine phosphorylation increases cell surface expression of SMS2 in COS7 cells. Cell surface proteins were labeled with sulfo-NHS-biotin and purified using streptavidin beads.(C) GPRC5B increases SMS2 protein abundance under metabolic stress. COS7 cells were co-transfected with SMS expression plasmids and either wild-type (5b-WT) or mutant GPRC5B (5b-YF) plasmids. After 6 hr of transfection, culture medium was replaced with serum-free medium containing BSA or palmitate-BSA complex (Palm) for 16 hr. An AcGFP expression plasmid was used as an internal standard to control transfection efficiency.(D) Tyrosine phosphorylation inhibits polyubiquitination of SMS2. HEK293 cells were co-transfected with the indicated expression plasmids. Polyubiquitination of SMS2 was detected from Flag immunoprecipitates by western blotting using anti-hemagglutinin (HA) antibody.(E) Palmitate treatment reduces polyubiquitination of SMS2. COS7 cells were co-transfected with the indicated expression plasmids. After 8 hr of palmitate treatment, polyubiquitination of SMS2 was detected.(A--C) Data are means ± SEM (n = 3; ANOVA, \*p \< 0.05, \*\*p \< 0.01, \*\*\*\*p \< 0.0001). See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

As differential intracellular localization of SMS1 and SMS2 may reflect their distinct functions, we sought to determine whether phosphorylation of SMS2 affects its localization in the PM. Cell surface biotin labeling revealed that tyrosine phosphorylation also increased SMS2 levels in the PM ([Figure 2](#fig2){ref-type="fig"}B).

Because persistent phosphorylation is required to produce elevated SMS2 levels, we examined whether GPRC5B controlled SMS2 levels by treating cells with palmitate and then measuring SMS1 and SMS2 levels. Palmitate significantly increased SMS2 levels in cells co-transfected with 5b-WT but not in cells co-transfected with 5b-YF ([Figure 2](#fig2){ref-type="fig"}C, right). Moreover, palmitate treatment did not affect SMS1 levels ([Figure 2](#fig2){ref-type="fig"}C, left). These observations suggest that GPRC5B mediates the persistent phosphorylation of SMS2 and that this phosphorylation depends on GPRC5B interaction with SMS2.

According to the hidden Markov model, SMS2 possesses six transmembrane domains ([Figure 3](#fig3){ref-type="fig"}A). The number of amino acids in the N- and C-terminal tails of human SMS2 accounts for approximately 41% of the total amino acids in the protein ([Figure 3](#fig3){ref-type="fig"}A). Prediction of intrinsically disordered regions in SMS2 reveals that most are located in the cytoplasmic tails ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}A). We speculate that SMS2 protein stability may be linked to a disorder-to-order transition induced by phosphorylation. Proteins containing long disordered segments tend to have a shorter half-life ([@bib39]). Therefore, we tested whether phosphorylation affects the ubiquitination of SMS2, because ubiquitination is the typical process by which unfolded proteins are degraded in cells. As expected, tyrosine phosphorylation remarkably suppressed the polyubiquitination of SMS2 ([Figure 2](#fig2){ref-type="fig"}D). Furthermore, palmitate treatment also apparently reduced the polyubiquitination of SMS2 ([Figure 2](#fig2){ref-type="fig"}E). On the other hand, phosphorylation moderately affected SMS1 ubiquitination, which depended on the extent of its phosphorylation by Fyn ([Figure S2](#mmc1){ref-type="supplementary-material"}B). These observations suggest that GPRC5B-mediated phosphorylation is linked to increased SMS2 levels under metabolic stress.Figure 3Phosphomimetic Mutations Increase SMS2 Protein Abundance(A) Illustration showing the putative transmembrane topology of SMS2. Identified phosphotyrosines (orange), cytoplasmic phosphotyrosine candidates (yellow), and active sites (green squares) in SMS2 are indicated. Intrinsically disordered region of SMS2 was predicted by Database of Disordered Protein Predictions (D^2^P^2^), <http://d2p2.pro/>.(B--D) Phosphomimetic mutations enhance SMS2 protein abundance. (B) HEK293 cells were co-transfected with expression plasmids for AcGFP and either wild-type (WT) or phosphomimetic mutants of SMS2-Flag. The expression levels of the indicated mutants were compared with that of Y56E mutant (hatched bars). (C) The expression levels of the indicated phosphomimetics were compared with that of phosphorylated wild-type SMS2 (hatched bars). (D) Multiple tyrosine-to-glutamate substitutions increased SMS2 expression levels compared with WT.(E) Phosphorylation or phosphomimetic mutation did not disrupt the enzymatic activity of SMS2. Super-SMS2 is a Y24/56/59/151/319/351E mutant. *In vitro* SM synthesis activity was analyzed by high-performance thin-layer chromatography (top). The phosphorylation status and the SMS amount in immunoprecipitates were confirmed by western blotting (bottom).(F) Super-SMS2 is less polyubiquitinated than wild-type SMS2. HEK293 cells were co-transfected with expression plasmids for hemagglutinin (HA)-ubiquitin plasmid and either SMS2-Flag or Super-SMS2-Flag for 24 hr. SMS2-Flag and Super-SMS2-Flag were immunoprecipitated using Flag beads. Polyubiquitination was detected using anti-HA antibody.(B--D) Data are means ± SEM (n = 3; ANOVA, \*\*p \< 0.01, \*\*\*p \< 0.001). ns, Not significant; ud, undetectable. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

Phosphomimetic Mutations Increase SMS2 Protein Abundance {#sec2.3}
--------------------------------------------------------

Using mass spectrometry, we identified three N-terminal tyrosine residues (Y24, Y56, and Y59) that were phosphorylated by Fyn-CA (data not shown; UniProtKB: Q8NHU3, phosphorylation residues were deposited in the PhosphoSitePlus database, <https://www.phosphosite.org/homeAction.action>). Other potential phosphotyrosine residues (Y151, Y243, Y319, and Y351) are evolutionarily conserved ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}B), indicating that they have a possible effect on SMS2 protein levels. However, the distribution of many basic amino acids around potential phosphotyrosine residues makes it difficult to determine whether these candidates are indeed phosphorylated. This is because the peptide fragments produced by protease digestion are too short to be analyzed using standard identification methods. To solve this problem, we used SMS2 mutants to determine whether site-specific mutations of SMS2 cytoplasmic tyrosine residues affect SMS2 protein levels.

Initially, we tested the effect of single point mutations (tyrosine to phenylalanine) or phosphomimetic mutations (tyrosine to glutamate) on SMS2 protein abundance. With the exception of cells transfected with Y59F and Y351F mutants, cells transfected with all the other tyrosine-to-phenylalanine mutants expressed decreased SMS2 levels compared with WT under basal conditions ([Figure S4](#mmc1){ref-type="supplementary-material"}A). In the presence of Fyn-CA, Y59F, Y151F, and Y351F mutants failed to reduce SMS2 expression compared with WT ([Figure S4](#mmc1){ref-type="supplementary-material"}B). On the other hand, all the single phosphomimetic mutations, except the Y351E mutant, increased SMS2 expression levels ([Figure S4](#mmc1){ref-type="supplementary-material"}C). However, cells expressing Y56E, Y243E, and Y351E mutants still showed increased SMS2 expression compared with cells expressing phosphorylated WT in the presence of Fyn-CA ([Figure S4](#mmc1){ref-type="supplementary-material"}B). We could not figure out site-specific mutations affecting SMS2 protein levels. For instance, the Y351F mutation had no effect on basal or phosphorylated expression levels ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). In addition, Y351E did not affect basal expression levels. However, cells expressing both Y351E and Fyn-CA still expressed elevated SMS2 levels, suggesting that this mutation affected phosphorylation of other tyrosine residues ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D). These findings indicate that multiple redundant tyrosine phosphorylation of residues regulates SMS2 protein levels.

We prepared various combinations of phosphomimetic mutants from Y56E ([Figures 3](#fig3){ref-type="fig"}B and 3C). Interestingly, double mutations comprising Y56E and Y243E failed to enhance expression ([Figures 3](#fig3){ref-type="fig"}B--3D), even though single mutations of either Y56E or Y243E increased expression compared with WT ([Figure S4](#mmc1){ref-type="supplementary-material"}C). This presumes that there is a plausible electrostatic interaction between the N terminus and the second cytoplasmic loop to maintain stability. In the analysis of various combinations of mutations at multiple tyrosine sites, the highest expression levels were observed in cells expressing mutations at Y24/56/59/151/319/351E ([Figure 3](#fig3){ref-type="fig"}D). This artificial construct, referred to as Super-SMS2, was used in further experiments. The enzymatic activity of SMS2 was not disrupted by tyrosine phosphorylation or phosphomimetic mutations ([Figure 3](#fig3){ref-type="fig"}E). Super-SMS2 showed reduced ubiquitination comparable to that of phosphorylated SMS2 ([Figure 3](#fig3){ref-type="fig"}F). Taken together, these observations suggest that redundant multiple phosphorylation of cytoplasmic tyrosine residues lead to reduced SMS2 ubiquitination and increased SMS2 protein abundance.

*GPRC5B* Deficiency Suppresses Palmitate-Induced Accumulation of Cer and DAG {#sec2.4}
----------------------------------------------------------------------------

Cer and DAG are important bioactive lipids that have been implicated in the regulation of cellular signaling pathways leading to insulin resistance under metabolic stress. Therefore, we determined whether *GPRC5B* affects the intracellular accumulation of Cer and DAG after palmitate exposure in mouse embryonic fibroblasts (MEFs). *GPRC5B* deficiency suppressed palmitate-induced accumulation of Cer and DAG ([Figures 4](#fig4){ref-type="fig"}A and 4B). We expected SM levels in WT cells to be elevated, because palmitate exposure increases SMS2 protein levels in a GPRC5B-dependent manner (cf. [Figure 1](#fig1){ref-type="fig"}E). However, palmitate exposure did not alter SM levels in either WT or *GPRC5B* knockout MEFs ([Figures 4](#fig4){ref-type="fig"}A and 4B), likely because of the tight regulation of SM homeostasis ([@bib25], [@bib34]).Figure 4*GPRC5B* Deficiency Suppresses Palmitate-Induced Accumulation of Cer and DAG(A and B) Lipid compositions of MEFs in the indicated culture conditions were analyzed by high-performance thin-layer chromatography (HPTLC). Lipids were extracted from cultured cells in serum-free medium supplemented with BSA or palmitate-BSA complex for 16 hr. (A) Total lipid extracts (left) and saponified lipids (right) were developed on an HPTLC plate and visualized with copper sulfate/phosphoric acid. (B) Quantification of SM, Cer, and DAG contents in MEFs.(C and D) Lipid compositions in MEFs analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). (C) LC-MS/MS analyses revealed that palmitate exposure induces *de novo* (sphinganine and dihydroceramides) and recycling (sphingosine and Cer) pathways for Cer synthesis in WT MEFs. (D) LC-MS/MS quantification of different molecular species of Cer and dihydroceramide.(E and F) Lipid compositions of *SMS2*−/− MEFs transfected with an expression plasmid for Super-SMS2. After 24 hr of transfection, cells were cultured in serum-free DMEM containing BSA or palmitate-BSA complex for 16 hr. Image of HPTLC plate (E) and quantification of the indicated lipids (F) are shown.(B--D) and (F) Data are means ± SEM (n = 3; ANOVA, \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001). ns, Not significant.

Lipid analysis using liquid chromatography-tandem mass spectrometry revealed that sphinganine and dihydroceramides---products of *de novo* sphingolipid synthesis---were elevated in WT cells compared with *GPRC5B* knockout cells under metabolic stress ([Figure 4](#fig4){ref-type="fig"}C). Palmitate exposure increased Cer and sphingosine levels in WT compared with *GPRC5B* knockout MEFs ([Figure 4](#fig4){ref-type="fig"}C). In WT cells, Cer species containing a C16:0 acyl chain were predominantly elevated, increasing by 4-fold approximately. Very-long-chain Cers increased by about 1.5-fold following palmitate exposure ([Figure 4](#fig4){ref-type="fig"}D). By contrast in WT cells, C16:0 dihydroceramide predominantly decreased compared with very-long-chain dihydroceramides ([Figure 4](#fig4){ref-type="fig"}D). This molecular species difference of the way dihydroceramides and Cers are affected suggests that palmitate-dependent accumulation of C16:0 Cer is generated via both *de novo* and recycling pathways.

Since GPRC5B mediated the increase in SMS2 levels in palmitate-treated cells, we next determined whether SMS2 affects the accumulation of Cer. Transfecting *SMS2* knockout cells with Super-SMS2 restored SM levels but did not affect palmitate-dependent Cer and DAG levels ([Figures 4](#fig4){ref-type="fig"}E and 4F). Further analysis of lipid content in *SMS1*, *SMS2*, and *SMS1/2* knockout cells revealed no apparent palmitate-dependent changes in lipid levels, although Cer and DAG levels were moderately elevated in *SMS1* knockout MEFs ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). These observations suggest that palmitate-dependent accumulation of Cer is independent of SMS2 activity.

GPRC5B Enhances Metabolic Stress-Induced Sphingolipid Metabolism {#sec2.5}
----------------------------------------------------------------

We next investigated the change in Cer flux after palmitate exposure. After 2 hr of pulse labeling with NBD-C6-Cer (N-\[6-\[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino\]hexanoyl\]-D-erythro-sphingosine), we quantified fluorescent Cer metabolites by high-performance thin-layer chromatography. Under basal conditions, total fluorescent lipid metabolites were comparable in WT and *GPRC5B* knockout MEFs ([Figure 5](#fig5){ref-type="fig"}A). Total fluorescent lipids were approximately 2-fold higher in WT than in *GPRC5B* knockout MEFs when cells were cultured in palmitate-containing medium ([Figure 5](#fig5){ref-type="fig"}A). NBD-derived SM, glucosylceramide (GlcCer), and Cer were elevated in WT cells compared with *GPRC5B* knockout MEFs under metabolic stress ([Figure 5](#fig5){ref-type="fig"}A). These observations suggest that GPRC5B increases the Cer pool in cellular membranes during metabolic stress. When cells were pulse labeled with NBD-SM for 2 hr, palmitate treatment slightly increased the total fluorescent lipid levels ([Figure 5](#fig5){ref-type="fig"}B). However, NBD-Cer and NBD-GlcCer showed an approximately 2-fold increase in WT compared with *GPRC5B* knockout MEFs under metabolic stress ([Figure 5](#fig5){ref-type="fig"}B). These results suggest that metabolic-stress-induced increase in sphingolipids is Cer dominant.Figure 5GPRC5B Enhances Metabolic Stress-Induced Sphingolipid Metabolism(A) Under metabolic stress, the level of Cer is greater in WT than in *GPRC5B* knockout MEFs. Cells were cultured in medium containing BSA or palmitate-BSA complex for 14 hr and then labeled with 5 μM NBD-ceramides for 2 hr at 37°C. Lipid extracts corresponding to the same amount of proteins were spotted onto high-performance thin-layer chromatography (HPTLC) plates and developed.(B) Increased SM degradation contributes to expansion of the Cer pool in palmitate-treated WT MEFs. Cells were cultured in medium containing BSA or palmitate-BSA complex for 14 hr and then labeled with NBD-SM for 2 hr at 37°C. Lipid extracts corresponding to the same amount of proteins were spotted onto HPTLC plates and developed.(C) NBD-SM flux in palmitate-treated cells. Cells were cultured in the presence or absence of palmitate-BSA complex for 14 hr and then labeled with 5 μM NBD-SM for 30 min on ice. Cells were washed three times and then chased in fresh medium and incubated at 37°C for the indicated times. Lipid extracts were spotted onto HPTLC plates and developed. Quantification of lipids is expressed as percentage of total fluorescence.(D) Inhibition of neutral sphingomyelinase, not of acid sphingomyelinase, blocks NBD-Cer formation from NBD-SM. Cells were pretreated with 10 μM GW4869 or 50 μM amitriptyline for 24 hr and then exposed to palmitate. After culturing in palmitate-containing media for 14 hr, cells were labeled with 5 μM NBD-SM for 30 min on ice and then chased in fresh medium.Data are means ± SEM (n = 3; ANOVA, \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001). See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

As mentioned above, palmitate-induced accumulation of Cer may come from two biosynthetic pathways, *de novo* and recycling. In the recycling pathway, sphingomyelinase-mediated degradation of SM is a key step for generating Cer ([@bib22]). In chase analysis, labeled NBD-SM was gradually degraded to NBD-Cer, which was used as a precursor for subsequent synthesis of NBD-GlcCer ([Figure S6](#mmc1){ref-type="supplementary-material"}). Under basal conditions, the NBD-SM degradation rate in WT and *GPRC5B* knockout MEFs was similar ([Figure 5](#fig5){ref-type="fig"}C). However, under metabolic stress, NBD-SM degradation and subsequent NBD-GlcCer synthesis occurred more rapidly in WT than in *GPRC5B* knockout MEFs ([Figures 5](#fig5){ref-type="fig"}C and [S6](#mmc1){ref-type="supplementary-material"}). Pretreating cells with GW4869, a selective inhibitor of neutral sphingomyelinase, inhibited NBD-Cer generation from NBD-SM, indicating that, during metabolic stress, the recycling pathway is enhanced ([Figure 5](#fig5){ref-type="fig"}D). Pretreating cells with amitriptyline, an inhibitor of acid sphingomyelinase, however, did not affect SM degradation ([Figure 5](#fig5){ref-type="fig"}D). Taken together, these observations are consistent with the results that GPCR5B mediates metabolic-stress-induced Cer accumulation through both *de novo* and recycling pathways.

Metabolic Stress Enhances SMS2-Mediated Generation of DAG {#sec2.6}
---------------------------------------------------------

Labeling cells with NBD-Cer is the typical method used to measure the *in situ* activity of GlcCer synthase and SM synthases ([@bib1], [@bib13]). Palmitate exposure changes lipid composition in cellular membrane. The accumulated Cer and DAG in cellular membrane may impede precise measuring of SMS activity, because SMS can also catalyze the reverse reaction ([@bib17], [@bib38]). Although pulse labeling with NBD-Cer showed that NBD-SM levels in WT MEFs are elevated under metabolic stress ([Figure 5](#fig5){ref-type="fig"}A), it was not obvious whether this was caused by increased SMS2 levels or by increased Cer levels. Therefore, we measure SMS2 activity by a modified method using NBD-PC ([@bib40]). The SMS-mediated biochemical reaction yields SM and DAG. This assay taps into the Cer-dependent generation of DAG from PC. Since cellular membranes contain much more PC than Cer or DAG, this method may minimize interference derived from endogenous DAG or Cer to measure SMS activity in cells.

We confirmed that Super-SMS2-transfected cells had the highest phosphorylcholine transferase activity using the conventional *in vitro* SMS assay ([@bib1]) ([Figure 6](#fig6){ref-type="fig"}A). In the assay of SMS activity using NBD-PC, a large increase in NBD-DAG was observed in cells co-labeled with NBD-PC and C6-Cer, indicating that NBD-DAG generation was apparently triggered by the addition of exogenous C6-Cer ([Figure 6](#fig6){ref-type="fig"}B). We then examined whether this reaction was catalyzed by SMS1 or SMS2. Transfection with expression constructs for SMS2 or Super-SMS2 significantly increased exogenous C6-Cer-dependent NBD-DAG production in *SMS1/2* double-knockout MEFs ([Figure 6](#fig6){ref-type="fig"}C). By contrast, transfection with empty vector or expression construct for SMS1 failed to produce NBD-DAG ([Figure 6](#fig6){ref-type="fig"}C). Palmitate exposure increased PC-derived DAG production in WT cells compared with that in *GPRC5B* knockout MEFs ([Figure 6](#fig6){ref-type="fig"}D). We confirmed that transfection of GPRC5B in *GPRC5B* knockout MEFs restored PC-derived DAG formation under metabolic stress ([Figure 6](#fig6){ref-type="fig"}E). These observations suggest that the increase of PC-derived DAG production in WT cells under palmitate-induced metabolic stress is caused by increased SMS2 protein levels or by increased endogenous Cer levels.Figure 6Metabolic Stress Enhances SMS2-Generated DAG(A) *In vitro* SMS assay. SMS2 was derived from cell lysates from *SMS1/2* double-knockout MEFs transfected with the indicated constructs. Equal protein amounts of cell lysate were mixed with liposomes prepared from egg PC and NBD-Cer and then incubated in 37°C for 1 hr. Lipids were extracted from the reaction mixture and then synthesized SM was measured by high-performance thin-layer chromatography (HPTLC).(B) Time course analysis of PC-derived DAG formation induced by the addition of exogenous C6-Cer. Cells were labeled with NBD-C6-PC alone or NBD-C6-PC plus C6-Cer for 30 min on ice, washed, and chased at the indicated times. Extracted lipids were developed via HPTLC, and fluorescence images were captured with a LAS3000 imaging system. To visualize total lipids, the same HPTLC plate was treated with cupric acid. PC-derived DAG was quantified from the fluorescence image.(C) SMS2 expression is required for Cer-Dependent DAG formation from PC. *SMS1/2* double-knockout MEFs were transfected with the indicated expression plasmids. After 48 hr of transfection, cells were labeled with NBD-PC or NBD-PC plus 5 μM C6-Cer for 30 min on ice and then washed twice and incubated at 37°C for 10 min. Fluorescence intensity of the extracted lipids was measured using a microplate reader, and the amount of lipids was determined. Same amount of fluorescent lipids was spotted on an HPTLC plate and developed.(D) *GPRC5B* deficiency reduces PC-derived DAG formation under metabolic stress. Cells were cultured in medium containing BSA or palmitate-BSA complex for 16 h and then labeled with NBD-PC for 30 min on ice. After NBD-PC labeling, cells were washed twice with fresh medium and incubated at 37°C for 15 min. The same amount of fluorescent lipids was spotted onto an HPTLC plate and developed.(E) GPRC5B enhances PC-derived DAG production by palmitate exposure. *GPRC5B* knockout MEFs were transfected with expression plasmid for human GPRC5B. After exposure to palmitate for 16 hr, cells were labeled with NBD-PC for 30 min on ice and then washed twice and incubated in 37°C for 15 min. NBD-DAG formation from NBD-PC were measured.(A--E) Data are means ± SEM (n = 3; ANOVA, \*\*p \< 0.01, \*\*\*\*p \< 0.0001).

SMS2-Generated DAG Is Responsible for JNK-Dependent Impairment of Insulin Signaling {#sec2.7}
-----------------------------------------------------------------------------------

Because Cer and DAG are bioactive lipids that are thought to impair insulin signaling, we measured insulin-evoked AKT activation in *SMS* knockout MEFs. Surprisingly, palmitate exposure failed to impair insulin signaling in *SMS2* knockout MEFs ([Figure 7](#fig7){ref-type="fig"}A), even though *SMS2*-null cells showed comparable accumulation of Cer and DAG under metabolic stress ([Figure S6](#mmc1){ref-type="supplementary-material"}).Figure 7SMS2-Generated DAG Is Responsible for JNK-Dependent Impairment of Insulin Signaling(A) *SMS2−/−* MEFs are insulin sensitive. Cells were pretreated with BSA or palmitate-BSA complex in serum-free medium for 16 hr and then stimulated with 1 nM insulin for 5 min. Insulin-induced phosphorylation (S473) of AKT was measured by western blotting.(B) Super-SMS2 expression inhibits insulin sensitivity. SMS2 or Super-SMS2 was expressed in *SMS2* knockout MEFs by transfection for 24 hr. After exposure in the medium containing 0.5 mM palmitate-BSA for 16 hr, cells were stimulated with 2 nM insulin for 5 min. AKT phosphorylation (S473) was measured by western blotting.(C) Super-SMS2 enhances palmitate-induced JNK activity. *SMS2−/−* MEFs were transfected with empty vector or expression plasmid for Super-SMS2. After 24 hr of transfection, cells were cultured in medium containing BSA or palmitate-BSA complex for 16 hr. Phosphorylation (T183/Y185) of active JNK and IRS1 (S1101) were measured by western blotting.(D) Super-SMS2 expression enhances the formation of metabolic-stress-induced DAG from PC. Transfection and culture conditions were the same as described in (C). Cells were labeled with NBD-PC for 30 min on ice. Cells were washed twice with fresh medium and then incubated in 37°C for 15 min.(E and F) *GPRC5B* deficiency lessens palmitate-induced insulin resistance (E) and JNK activity (F). Wild-type and *GPRC5B−/−* MEFs were cultured in serum-free medium supplemented with BSA or palmitate-BSA complex for 16 hr. Cells were stimulated with 1 nM insulin for 5 min.(G) Expression of Super-SMS2 in *GPRC5B−/−* MEFs restores palmitate-induced insulin resistance and JNK activation. Experimental conditions were the same as described in (B).(H) Schematic diagram illustrating SMS2-mediated insulin resistance under metabolic stress. Metabolic stress induces SMS2 phosphorylation, which results in SMS2 upregulation. In parallel, metabolic stress also induces the accumulation of Cer, which are readily converted to SM to produce DAG via SMS2 in the plasma membrane. SMS2-produced DAG is considered to be a second messenger that activates the PKC-JNK axis. This is the primary means of impairing insulin action.(B--G) Data are means ± SEM (n = 3; ANOVA, \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001). ns, Not significant. See also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}.

It is well known that DAG is a potent mediator for the activation of PKC ([@bib35]). Transfecting *SMS2* knockout MEFs with either SMS2 or Super-SMS2 restored palmitate-induced insulin resistance ([Figure 7](#fig7){ref-type="fig"}B). Expression of Super-SMS2 in *SMS2* knockout MEFs was sufficient to activate JNK under metabolic stress ([Figure 7](#fig7){ref-type="fig"}C). In addition, we observed increased phosphorylation of IRS1 (Ser1101) in Super-SMS2-transfected MEFs, suggesting that PKCθ was activated ([@bib23]) ([Figure 7](#fig7){ref-type="fig"}C). Importantly, we also observed a remarkable elevation of PC-derived DAG formation in Super-SMS2-transfected MEFs ([Figure 7](#fig7){ref-type="fig"}D) that was strongly correlated with JNK activation ([Figure 7](#fig7){ref-type="fig"}C). This suggests that SMS2-generated DAG is a critical mediator of palmitate-induced impairment of insulin signaling via PKC-JNK axis.

We next examined insulin signaling in *GPRC5B* knockout MEFs under metabolic stress. As expected, insulin-evoked AKT phosphorylation was increased in *GPRC5B* knockout MEFs compared with that in WT ([Figure 7](#fig7){ref-type="fig"}E). This indicated that *GPRC5B* deficiency protected the cells from lipid-induced insulin resistance. At the same time, palmitate-induced JNK activity was higher in WT than in *GPRC5B* knockout MEFs ([Figure 7](#fig7){ref-type="fig"}F). Since palmitate treatment increases SMS2-generated DAG in WT cells ([Figures 6](#fig6){ref-type="fig"}D and 6E), it suggests that GPRC5B mediates SMS2-generated DAG production leading to JNK-dependent insulin resistance. We demonstrated that transfection of Super-SMS2, but not of SMS2, into *GPRC5B* knockout MEFs impairs insulin signaling under metabolic stress ([Figure 7](#fig7){ref-type="fig"}G). Taken together, these observations provide evidence that GPRC5B plays a critical role in palmitate-induced insulin resistance by regulating sphingolipid metabolism at the cellular and molecular levels.

In summary, we demonstrated that palmitate exposure increases SMS2 levels through a GPRC5B-mediated tyrosine phosphorylation. With metabolic stress, GPRC5B recruitment of SFK plays an important role in the phosphorylation of SMS2. Concurrently, GPRC5B activates *de novo* Cer synthesis and Cer recycling pathways, causing Cer to accumulate, which is required for the generation of DAG by SMS2. Thus, under conditions of metabolic stress, SMS2-generated DAG plays a pivotal role in impairing insulin signaling by enhancing the PKC-JNK signaling axis. These events are summarized in [Figure 7](#fig7){ref-type="fig"}H.

Discussion {#sec3}
==========

Understanding the physiological mechanism underlying saturated-FFA-induced insulin resistance has remained elusive for many years, because several complicated pathways including lipid metabolism and signal transduction are involved. In the present study, *GPRC5B* knockout MEFs limit the accumulation of Cer and DAG induced by palmitate exposure ([Figures 4](#fig4){ref-type="fig"}A--4D). This is accompanied by a reduction in SM degradation ([Figures 5](#fig5){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}), suggesting that palmitate-induced Cer accumulation occurs not only through *de novo* Cer synthesis but also through Cer recycling pathways. Activated recycling pathways may also contribute to tight regulation of SM homeostasis. In our experiments, palmitate did not alter SM levels ([Figures 4](#fig4){ref-type="fig"}A and 4B), even though a GPRC5B-mediated event increased SMS2 levels in palmitate-treated cells ([Figure 2](#fig2){ref-type="fig"}C). This is consistent with modest changes in SM content reported for CHO cells overexpressing SMS1 and SMS2, and in cells in which SMS was knocked down using small interfering RNA([@bib8]).

To understand how Cers are related to the development of insulin resistance, it is important to consider their subcellular localization. Cers are synthesized in the ER and are rapidly converted to SM or glucosylceramides in the Golgi apparatus, whereby Cer transport protein (CERT) plays a key role in SM synthesis ([@bib14]). SMS1-induced DAG-dependent protein kinase D (PKD) activation at the Golgi apparatus negatively regulates CERT activity by controlling phosphoinositide 4-phosphate levels ([@bib4]). This negative feedback loop governs the central metabolic flow of sphingolipids. Consequently, this may restrict SM and DAG levels at the Golgi apparatus. By contrast, sphingolipid metabolism at the PM, in particular the recycling pathway, is different from what occurs at the Golgi apparatus. In the present study, we observed that PC-derived DAG production is completely dependent on SMS2, but not SMS1 activity, which reflects different DAG subcellular compartments ([Figure 6](#fig6){ref-type="fig"}C). Cer-dependent insulin resistance may occur by blocking the translocation of AKT to the PM ([@bib31]), or by activating protein phosphatase 2A-dephosphorylated AKT ([@bib5], [@bib36]). Despite considerable Cer accumulation in palmitate-treated *SMS2* knockout MEFs ([Figure S6](#mmc1){ref-type="supplementary-material"}), we did not observe impaired insulin signaling in *SMS2* knockout MEFs ([Figures 7](#fig7){ref-type="fig"}A and 7B).

Like Cers, DAG is also an important bioactive lipid related to insulin resistance. Increased intracellular DAG leads to activation of PKCθ and PKCɛ in skeletal muscle and liver, respectively, which, in turn, results in impaired IRS1-IRS2-dependent insulin signaling ([@bib10], [@bib19], [@bib23], [@bib33]). In our model system, palmitate-induced DAG accumulation may be generally accomplished by *de novo* synthesis; DAG is synthesized by the subsequent esterification of fatty acyl-CoA to glycerol-3-phosphate and dephosphorylation in the ER. We demonstrated that there are no apparent changes in the extent of palmitate-induced DAG accumulation between WT and *SMS2* knockout MEFs ([Figure S6](#mmc1){ref-type="supplementary-material"}). Nevertheless, insulin sensitivity is not disrupted in *SMS2* knockout MEFs ([Figure 7](#fig7){ref-type="fig"}A). Very importantly, palmitate-dependent impairment of insulin signaling is strongly correlated with SMS2-generated DAG ([Figures 6](#fig6){ref-type="fig"}B--6E, and [7](#fig7){ref-type="fig"}D). A high expression level of SMS2 exacerbates palmitate-induced insulin resistance ([Figures 7](#fig7){ref-type="fig"}B and 7G). These results suggest that the DAG compartment in the PM strongly affects the triggering signaling cascades related to insulin resistance, rather than intracellular DAG in the ER.

Saturated fatty acids activate JNK signaling pathway. This activation is critical for impairing insulin action ([@bib18]). Tyrosine phosphorylation events mediated by c-Src or Fyn are required for palmitate-induced JNK activation in fibroblasts ([@bib16], [@bib20]). We confirmed that pretreatment of SFK inhibitor prevents palmitate-stimulated JNK activation ([Figure S7](#mmc1){ref-type="supplementary-material"}A). PKCs are also critical for palmitate-induced JNK activation related to insulin resistance. Loss of PKCs prevents palmitate-stimulated JNK activation ([@bib18]). PMA-induced JNK activation is not altered in *GPRC5B* knockout MEFs, indicating that the PKC-JNK axis is intact in these cells ([Figure 7](#fig7){ref-type="fig"}B). We demonstrated that SMS2-produced DAG is sufficient for activating JNK ([Figures 7](#fig7){ref-type="fig"}C and 7G). This suggests that SMS2 expression in this pathway is functionally significant.

SMS1 and SMS2 are essential enzymes for SM synthesis. However, there is little evidence to show how they are regulated. In the present study, we demonstrated that GPRC5B and SMS2 show increased association, and subsequent tyrosine phosphorylation by recruiting an SFK occurs in palmitate-exposed cells ([Figures 1](#fig1){ref-type="fig"}B--1E). Multiple phosphorylation on cytoplasmic tyrosine residues plays an important role in regulating SMS2 protein abundance ([Figures 2](#fig2){ref-type="fig"} and [S1](#mmc1){ref-type="supplementary-material"}). Thus a transmembrane adapter-like function of GPRC5B is critical for the cellular response to palmitate excess. We conclude that GPRC5B plays a key role in the mechanism underlying the formation of SMS2-generated DAG during metabolic stress-associated sphingolipid metabolism, which is required for lipid-induced insulin resistance. We believe that our findings contribute to a deeper understanding of the role of sphingolipid metabolism in the maintenance of cellular homeostasis and controlling the cellular metabolic stress response.

Limitations of the Study {#sec3.1}
------------------------

We emphasize that our results demonstrate GPRC5B-mediated phosphorylation and accumulation of SMS2 under metabolic stress conditions in transfected cell lines. Although we demonstrated the increased DAG generation mediated by SMS2 activity in palmitate-treated MEFs, we could not show a concomitant increase of endogenous SMS2 protein abundance in MEFs. The increased SMS2-mediated DAG generation in palmitate-treated MEFs likely represents a critical step for lipid-induced insulin resistance. Absence of validated SMS1 and SMS2 antibodies for use in cultured cells and mice limited further experimental insights in this study.

We note that our results highlight the biological significance of GPRC5B and SMS2 in cellular model systems under metabolic stress, but further investigations *in vivo* are required to clarify the pathophysiological role of GPRC5B in obesity and type 2 diabetes.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Software Availability {#appsec3}
==============================

Intrinsically disordered regions in SMS1 and SMS2 were predicted by the Database of Disordered Protein Predictions (D^2^P^2^, <http://d2p2.pro/>)

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods and Figures S1--S7
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